A
ATX
AMPLIA THERAPEUTICS
0.175
-0.065-27.08%Opening11:29 04/07 AEST
OPEN/PREV CLOSE0.170/0.170
TODAY RANGE0.155-0.175
VOL8.81M
MARKET CAP79.53M
52 WEEK RANGE0.049-0.425
AVG VOL (3M)6.33M
% TURNOVER1.72%
TURNOVER1.43M
P/E (TTM)-7.5980
% RANGE11.76%
EPS(TTM)-0.0204
P/E(FORWARD)-7.7500
P/B1.852
BVPS0.084
DIVIDEND--
P/S15.98
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP67.41M
SHARES OUTSTANDING513.07M
NEXT EARNINGS05/28-06/01
FREE FLOAT434.91M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
The Motley Fool·2d ago
Down 30% today, is it time to buy into this beaten down biotech share?
The Motley Fool·03/23 21:42
Why this promising small-cap ASX stock could rise almost 80%
ASX·03/22 22:37
Amplia Reports Improved Responses & Survival in ACCENT trial
ASX·03/18 23:58
Trading Halt
ASX·03/18 22:54
Pause in Trading
ASX·03/08 21:16
Benefit of Narmafotinib in kRas-Mutated Cancer Models
ASX·02/24 21:11
Appointment of Chief Financial Officer
ASX·02/17 21:16
Amplia Emergence 2026 Conference Presentation
ASX·02/10 22:10
US Sites For AMPLICITY Pancreatic Cancer Trial Open
ASX·01/30 00:00
AMPLIA THERAPEUTICS LIMITED Prelim Q4
ASX·01/22 05:46
Change in substantial holding
ASX·01/21 21:22
Narmafotinib Large-Scale Manufacture Complete
ASX·01/09 05:22
ACCENT Data Presented at 2026 ASCO GI Cancer Symposium
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others